MEDecision, Inc. (Nasdaq: MEDE), a leading provider of collaborative health care management solutions, today announced that it will deliver its Alineo๏ฟฝ Collaborative Health Care Management technology to DC Chartered Health Plan, Inc. (Chartered), a Washington, D.C. Medicaid provider with more than 75,000 members. Chartered plans to use Alineo to meet certain disease management requirements set forth in its recently-renewed Medicaid contract, particularly National Committee for Quality Assurance (NCQA) and Healthcare Effectiveness Data and Information Set (HEDIS) accreditations. Alineo๏ฟฝs flexibility will enable the insurer to begin working with the technology immediately with the goal of having it fully implemented by the end of the year. MEDecision will host the solution as an Internet service provider (ISP). ๏ฟฝThis deal underscores the tremendous momentum Alineo has enjoyed in the marketplace since its release earlier this year, and is a strong validation of our vision for the future of health information technology,๏ฟฝ said MEDecision Founder and CEO David St.Clair. ๏ฟฝAlineo is an ideal solution for Chartered๏ฟฝs needs and we๏ฟฝre confident they๏ฟฝll see the benefits of its simplified, smart and state-of-the art technology in short order.๏ฟฝ Alineo is a collaborative health care management platform for addressing case management, disease management and utilization management. Through an innovative member-centric approach, it analyzes, applies and automates payer-driven best practices. Alineo enables health plans to streamline operational efficiencies, reduce waste and increase care quality by helping them enhance business agility, control costs and optimally manage risk and compliance. ๏ฟฝWe were very impressed by the breadth and depth of Alineo๏ฟฝs clinical intelligence and care management capabilities, which were crucial components for us in our evaluation of competing technologies,๏ฟฝ said Lavdena Adams Orr, M.D., FAAP, Chartered๏ฟฝs chief medical officer. ๏ฟฝIt is a robust solution that we can implement relatively quickly. It will enable us to function more efficiently from an organizational standpoint, and help streamline our NCQA and HEDIS compliance, which is a very important component of our overall operations.๏ฟฝ For more information, please visit www.MEDecision.com. About MEDecision MEDecision offers collaborative health care management solutions that provide a simplified and smart way to manage the health of members and member populations which can improve the quality and affordability of care. Based on state-of-the-art technology, MEDecision's solutions include Alineo๏ฟฝ, a collaborative health care management platform for managing case, disease and utilization management and Nexalign๏ฟฝ, a collaborative health care information exchange service. MEDecision believes that, in the aggregate, its health care payer customers insure or manage care for approximately one in every six people in the U.S. with health insurance. For more information, please visit www.MEDecision.com. About DC Chartered Health Plan, Inc. Established in 1987, D.C. Chartered Health Plan, Inc., (Chartered) is the largest private sector, minority-owned and operated managed care organization, currently participating in the District of Columbia DC Healthy Families (Medicaid) and DC Healthcare Alliance Programs. Chartered serves more than 75,000 members and is dedicated to providing high quality health care services to their members. This commitment led to Chartered being accredited by the National Committee of Quality Assurance (NCQA) at the commendable level. Chartered๏ฟฝs mission is to enhance access to and the delivery of health care services throughout its diverse communities. For more information, please visit www.chartered-health.com. MEDecision is a trademark of MEDecision, Inc. The MEDecision logo and product names are also trademarks or registered trademarks of MEDecision, Inc. Other product and brand names are trademarks of their respective owners. MEDE-G
Medecision (MM) (NASDAQ:MEDE)
๊ณผ๊ฑฐ ๋ฐ์ดํ„ฐ ์ฃผ์‹ ์ฐจํŠธ
๋ถ€ํ„ฐ 5์›”(5) 2024 ์œผ๋กœ 6์›”(6) 2024 Medecision (MM) ์ฐจํŠธ๋ฅผ ๋” ๋ณด๋ ค๋ฉด ์—ฌ๊ธฐ๋ฅผ ํด๋ฆญ.
Medecision (MM) (NASDAQ:MEDE)
๊ณผ๊ฑฐ ๋ฐ์ดํ„ฐ ์ฃผ์‹ ์ฐจํŠธ
๋ถ€ํ„ฐ 6์›”(6) 2023 ์œผ๋กœ 6์›”(6) 2024 Medecision (MM) ์ฐจํŠธ๋ฅผ ๋” ๋ณด๋ ค๋ฉด ์—ฌ๊ธฐ๋ฅผ ํด๋ฆญ.